Health Decision Strategies, LLC.


Expected Value of Perfect Information (EVPI)
Incremental Net Benefit Analysis (INB)
Cost Effectiveness Acceptability Curve (CEAC)
Incremental Cost Effectiveness Ratio (ICER)
Online Calculator and Graphs
Data Submission Form

(Beta test, not for official use)

Number of Boostrap replications to calculate.

Caution: More than 1000 bootstrap replications will run slowly
or may require you to restart your browser.
Data Entry Form
(comma separated pairs only)
You can cut and paste new data into text boxes.

Control Group (Effect,Cost)

Treatment Group (Effect,Cost)

 

 

Above is Dataset #1.
You can "cut and paste" your own comma-delimited data in the boxes above or
you can select any of three other datasets below.

Dataset #2. Cardiovascular Dataset A.

Dataset #3. Cardiovascular Dataset B.

Dataset #4. Antidepressant Dataset.

Dataset #5. Rapid MRI Dataset.

REFERENCES:

Dataset 1. Nixon RM, Wonderling D and Grieve R. How to estimate cost-effectiveness acceptability curves, confidence ellipses and incremental net benefits alongside randomised controlled trials. MRC Biostatistics Unit, Cambridge UK. 2005/4.

Dataset 1. Wonderling D, Vickers AJ, Grieve R, McCarney R. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. BMJ 2004;328:747.

Dataset 2. Kerelakes DJ, Obenchain RL et al. Abciximab provides cost-effective survival advantage in high-volume interventional practice. Am. Heart J. 140:603-10; 2000.

Dataset 3. Glick H, Polsky D. Comparing costs and effects in economic assessments. ISPOR Shortcourse. May 17, 2003. www.uphs.upenn.edu/dgimhsr.

Dataset 4. Obenchain RL et al. Bootstrap analyses of cost effectiveness in antidepressant pharmacotherapy. Pharmacoeconomics. 1997 May;11(5):464-472.

Dataset 5. Jarvik JG et al. Rapid magnetic resonance imaging vs radiographs for patients with low back pain. JAMA 2003 June; 289(21): 2810-2818.


Health Decision Strategies, LLC.
Calculator developed by Health Decision Strategies, LLC